Уноси

• Potential Strategies to Limit Inappropriate Purchasing of Antibiotics without a Prescription in a Rural Province in South Africa: Pilot Study and the Implications (2024-01)

  T. Milta Sono, M. Maluleka, А. Голић, S. Campbell, V. Marković Peković, N. Schellack, S. Kumar, B. Godman, J. Meyer, Potential Strategies to Limit Inappropriate Purchasing of Antibiotics without a Prescription in a Rural Province in South Africa: Pilot Study and the Implications, Advances in Human Biology, Vol. 1, No. 14, pp. 60 - 67, Jan, 2024

• Pilot Study to Evaluate the Feasibility of a Patient Questionnaire for the Purpose of Investigating the Extent of Purchasing Antibiotics without a Prescription in a Rural Province in South Africa: Rationale and Implications (2024-03)

  T. Milta Sono, M. Maluleka, N. Ramdas, А. Голић, S. Campbell, V. Marković Peković, N. Schellack, S. Kumar, B. Godman, J. Meyer, Pilot Study to Evaluate the Feasibility of a Patient Questionnaire for the Purpose of Investigating the Extent of Purchasing Antibiotics without a Prescription in a Rural Province in South Africa: Rationale and Implications, Advances in Human Biology, Vol. 2, No. 14, pp. 138 - 147, Mar, 2024

• Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance (2023-04)

  T. Milta Sono, E. Yeika, A. Cook, A. Kalungia, S. Opanga, J. Acolatse, I. Sefah, A. Golić, S. Campbell, G. Lorenzetti, Z. Ul Mustafa, V. Marković Peković, A. Kurdi, B. Paramadhas, G. Rwegerera, A. Amu, M. Alabi, E. Wesangula, M. Oluka, F. Khuluza, I. Chikowe, J. Fadare, O. Ogunleye, D. Kibule, E. Hango, N. Schellack, N. Ramdas, A. Massele, S. Mudenda, I. Hoxha, C. Moore, B. Godman, J. Meyer, Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance, Expert Rev Anti Infect Ther, Vol. 21, No. 10, pp. 1025 - 1055, Apr, 2023

• Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets (2018-12)

  B. Godman, A. Bucsics, P. Vella Bonanno, W. Oortwijn, C. Rothe, A. Ferrario, S. Bosselli, A. Hill, A. Martin, S. Simoens, A. Kurdi, M. Gad, J. Gulbinovic, A. Timoney, T. Bochenek, A. Salem, I. Hoxha, R. Sauermann, A. Massele, A. Guerra Junior, G. Petrova, Z. Mitkova, G. Achniotou, O. Laius, C. Sermet, G. Selke, V. Kourafalos, J. Yfantopoulos, E. Magnusson, R. Joppi, M. Oluka, H. Kwon, A. Jakupi, F. Kalemeera, J. Fadare, O. Melien, M. Pomorski, M. Wladysiuk, V. Marković Peković, I. Mardare, D. Meshkov, T. Novakovic, J. Furst, D. Tomek, C. Zara, E. diogene, J. Meyer, R. Malmstrom, B. Wettermark, Z. Matsebula, S. Campbell, A. Haycox, Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets, Frontiers in public health, Vol. 6, No. Article 328, pp. 1 - 21, Dec, 2018

• Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries (2020-02)

  B. Godman, H. McCabe, T. Leong, D. Mueller, A. Martin, I. Hoxha, J. Mwita, G. Rwegerera, A. Massele, J. Costa, R. Nascimento, L. Lovato, K. Tachkov, P. Milushewa, O. Patrick, L. Niba, O. Laius, I. Sefah, S. Abdulsalim, F. Soleymani, L. Achieng, A. Guantai, M. Oluka, A. Jakupi, K. Logviss, M. Hassali, D. Kibule, F. Kalemeera, M. Mubita, I. Mardare, A. Alrasheedy, J. Furst, D. Tomek, V. Marković Peković, T. Phuong, B. Thanh, A. Kalungia, T. Zaranyika, N. Masuka, I. Olaru, J. Wale, R. Hill, A. Kurdi, A. Timoney, S. Campbell, J. Meyer, Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries, Expert Review of Pharmacoeconomics & Outcome Research, Vol. 20, No. 1, pp. 1 - 26, Feb, 2020

• Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications (2021-03)

  B. Godman, A. Hill, S. Simoens, G. Selke, I. Selke Krulichova, C. Zampirolli, A. Martin, W. Oortwijn, A. Timoney, L. Gustafsson, L. Vončina, H. Kwon, J. Gulbinovic, D. Gotham, J. Wale, W. da Silva, T. Bochenek, A. Kurdi, E. Allocati, O. Ogunleye, J. Meyer, I. Hoxha, A. Malaj, C. Hierlander, R. Sauremann, W. Hamelinck, G. Petrova, O. Laius, I. Langner, J. Yfantopoulos, R. Joppi, A. Jakupi, I. Greičiute-Kuprijanov, P. Vella Bonanno, H. Piepenbrink, V. de Valk, M. Wladysiuk, V. Marković Peković, I. Mardare, J. Furst, D. Tomek, M. Obach Cortadellas, C. Zara, C. Pontes, S. McTaggart, T. Laba, O. Melien, D. Wong-Rieger, S. Bae, R. Hill, Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications, Expert Review of Pharmacoeconomics & Outcome Research, Vol. 21, No. 4, pp. 527 - 540, Mar, 2021

• Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries (2021-06)

  B. Godman, A. Egwuenu, M. Haque, O. Malande, N. Schellack, S. Kumar, Z. Saleem, J. Sneddon, I. Hoxha, S. Islam, J. Mwita, R. Nascimento, I. Godoi, L. Niba, A. Amu, J. Acolatse, R. Incoom, I. Sefah, S. Opanga, A. Kurdi, I. Chikowe, F. Khuluza, D. Kibule, O. Ogunleye, A. Olalekan, V. Marković Peković, J. Meyer, A. Alfadl, T. Phuong, A. Kalungia, S. Campbell, A. Pisana, J. Wale, A. Seaton, Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries, Life , Vol. 11, No. 6, pp. 1 - 43, Jun, 2021

• Evidence-based public policy making for medicines across countries: findings and implications for the future (2021-08)

  B. Godman, J. Fadare, H. Kwon, C. Zampirolli, A. Kurdi, I. Piassi, D. Kibule, I. Hoxha, S. Opanga, Z. Saleem, T. Bochenek, V. Marković Peković, I. Mardare, A. Kalungia, S. Campbell, E. Allocati, A. Pisana, A. Martin, J. Meyer, Evidence-based public policy making for medicines across countries: findings and implications for the future, Journal of Comparative Effectiveness Research, Vol. 10, No. 12, pp. 1019 - 1052, Aug, 2021